Patient-Derived Organoids for Semi-Automated Drug Screening & Their Utilization for Building Higher Complexity Models

Time: 3:30 pm
day: Day Two


  • Utilisation of ovarian cancer organoids for medium throughput semi-automated drug screening showcasing correlation with clinical response
  • Utilisation of colon organoids to build the complexity of the gut in health and disease